Close

OUR NEWS

Qualia Pharma announces the introduction of Vergenix™FG in the Greek Market

Vergenix™FG, is an innovative flow able wound – filler of recombinant type I human collagen derived from bioengineered tobacco plants, charts a new course in the treatment of acute and chronic wounds.

Qualia Pharma announces the introduction of the new way of administrating Vitamin B12

Vitamin B12 Qualia Spray ® is a modern food supplement that ensures full and immediate absorption of vitamin B12. Vitamin B12 Qualia Spray can restore vitamin B12 deficiency.

Qualia Pharma participated in the 2nd Health Innovation Conference

The emergence of innovative health solutions was the goal of the 2nd Health Innovation Conference which took place on May 17, 2018, at the National Insurance Conference Center.

Bloomberg: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus

Enzymatica has entered into a distribution agreement with Qualia Pharma for marketing and sales of ColdZyme® Mouth Spray on the Greek and Cypriot market.

Qualia Pharma completes acquisition of Life NLB

Acquisition reinforces Qualia’s strategy and opens new opportunities for growth in Greece and abroad.

Holiday Wishes

Children visited our premises to decorate the Christmas tree and create a wall full of Joy. Merry Christmas & Happy New Year.

A Greek Alliance against Alzheimer’s disease

Qualia Pharma and Bionature signed a collaboration agreement on the clinical development of a novel class of molecules (called Microneurotrophins) for treating Alzheimer’s disease.

Interview: Fotis Sakellaridis

The pharmacy trade magazine “Anavathmisi Pharmakion” hosts a personal interview from the CEO of Qualia pharma, Mr. Fotis Sakellaridis.

Biominerals NV : Business visit

It was a great pleasure to welcome to our premises Mr Geert Wirtz, CEO BioMinerals NV and Richard Passwater Jr, BioMinerals USA.

The winners of the pharmacy contest

Today, under an official notary process, we are pleased to announce the names of the 3 winners of our pharmacy contest.

VALUEMAG is approved by Horizon 2020

European Commission announced today, that the project VALUMAG will be financed under the program Horizon 2020 with the amount of 4.7 million €.

Pharmacy contest

Today, a big pharmacy contest has been launched by Qualia Consumer Health.